RxDoctor Payments Data

Christopher Finley, DO

Surgery · Port Charlotte, FLNPI 1720414527

Payments from drug & device makers

$2,105in general payments, 2019–2025

Across 45 payments — averaging $46.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$969
  • Novo Nordisk$155
  • Davol Inc.$137
  • Johnson & Johnson$113
  • TELA Bio, Inc.$78
  • Heron Therapeutics, Inc.$73
  • plus $580 from 17 others

What the payments were for

  • Travel & lodging$96946%
  • Food & beverage$1,13654%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,105 in reported general payments places this provider in the 40th percentile of 1,569 surgery providers in Florida.

See all surgery providers in Florida

Medicare billing

Part B allowed, 2024
$205,722
Medicare patients
353
Services billed
917

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide90$104,558
LinzessLinaclotide47$36,229
Ursodiol44$2,481
Omeprazole241$2,338
Ondansetron Hcl35$2,170
Sucralfate88$1,077
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen162$808
Pantoprazole Sodium43$370
Dicyclomine Hcl30$330
Promethazine Hcl41$192
Famotidine26$141
Tramadol Hcl17$28

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$155$104,55890 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,569 surgery providers in Florida.

Other surgery in Port Charlotte

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →